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Background: The aim of this study was to evaluate the ability of intraoperative neuromonitoring in reducing the
postoperative recurrent laryngeal nerve palsy rate by a comparison between patients submitted to thyroidectomy
with intraoperative neuromonitoring and with routine identification alone.
Methods: Between June 2007 and December 2012, 2034 consecutive patients underwent thyroidectomy by a
single surgical team. We compared patients who have had neuromonitoring and patients who have undergone
surgery with nerve visualization alone. Patients in which neuromonitoring was not utilized (Group A) were 993,
patients in which was utilized (group B) were 1041.
Results: In group A 28 recurrent laryngeal nerve injuries were observed (2.82%), 21 (2.11%) transient and 7 (0.7%)
permanent. In group B 23 recurrent laryngeal nerve injuries were observed (2.21%), in 17 cases (1.63%) transient
and in 6 (0.58%) permanent. Differences were not statistically significative.
Conclusions: Visual nerve identification remains the gold standard of recurrent laryngeal nerve management in
thyroid surgery. Neuromonitoring helps to identify the nerve, in particular in difficult cases, but it did not decrease
nerve injuries compared with visualization alone. Future studies are warranted to evaluate the benefit of intraoperative
neuromonitoring in thyroidectomy, especially in conditions in which the recurrent nerve is at high risk of injury.
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Operation on the thyroid gland are the most frequently
performed endocrine procedures worldwide. Improvements
in technique have decreased the risk of injury to adjacent
structures to minimal levels [1]. Apart from hypoparathyr-
oidism [2,3] and hematoma [3,4], recurrent laryngeal nerve
palsy is the most common and serious complication
after thyroid surgery [2,3,5,6] and it is the leading cause
of medicolegal litigation after endocrine surgery [2,3,7].
The rate of recurrent laryngeal nerve palsy varies from
0.5 to 20% depending on the type of disease (benign or* Correspondence: pgcalo@unica.it
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unless otherwise stated.malignant), the type of surgery (first time or reopera-
tion), the extent of resection, and the surgical technique
[5,6,8-14]; abnormal anatomy, bulky disease and surgeon
inexperience are additional risk factors of recurrent laryn-
geal nerve injury [3,6,8,15-17].
Recurrent laryngeal nerve injury can diminish quality
of life due to a variety of symptoms related to voice changes
and subsequent limitations in physical, emotional and social
functioning, while bilateral injury can be a life-threatening
complication leading to airway obstruction [6,18,19].
Intraoperative identification of the recurrent laryngeal
nerve has been demonstrated to decrease the incidence
of postoperative nerve palsy [5-7,15,18,20,21]. But even
in the most experienced hands recurrent laryngeal nerved. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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1-2% and temporary palsy rate of up to 5-6%, owing to
variability in nerve anatomy and difficulties in nerve
identification [2,5,15,22-26].
The causes of recurrent laryngeal nerve injury could
result from transaction, clamping, stretching, electro-
thermal injury, ligature entrapment, or ischemia [24,27-30];
several studies have reported that anatomical variations
of the recurrent laryngeal nerve, such as extralaryngeal
branches, distorted recurrent laryngeal nerve, intertwining
between branches of the recurrent laryngeal nerve and in-
ferior thyroid artery and non-recurrent laryngeal nerve,
play an important role in the occurrence of nerve injury
that can be caused by visual misidentification [24].
In recent years, increasing attention has been paid to
the use of neuromonitoring devices to reduce the risk of
nerve injury during thyroid surgery [15,31]. Many studies
reported a high negative predictive value of 92-100% but a
low and highly variable positive predictive value of 10-90%
[2,32]. Recurrent laryngeal nerve monitoring is being used
with increasing frequency in the United States during
thyroidectomy, partly driven by the medico-legal system
[10,22,33-35] while German surgeons use the method
routinely even much more often than the Americans
[1]; the rates of the use of neuromonitoring have recently
become almost equivalent between general surgery- and
otolaryngology-trained surgeons [14,22,36]. However, the
use of recurrent laryngeal nerve monitoring is associated
with increased time of setup and increased cost of equip-
ment by about 5-7% [1,33]. The economic impact is
considerable, owing to the costs of the technology,
which, for the entire equipment set-up, could vary from
15,000 to 20,000 Euro [25,37].
The aim of the present retrospective study was to
evaluate the ability of this technique to predict the postop-
erative functional outcome and the role of intraoperative
neuromonitoring in reducing the postoperative recurrent
laryngeal nerve palsy rate by a comparison between pa-
tients submitted to thyroidectomy with intraoperative
neuromonitoring and with routine identification alone
in a single endocrine surgical centre.
Methods
Between June 2007 and December 2012, 2034 consecu-
tive patients underwent thyroidectomy by a single surgical
team. 1749 patients were submitted to total thyroidectomy,
231 to total thyroidectomy with VI level lymphectomy, and
54 underwent completion total thyroidectomy. 1615 were
female and 419 male with a mean age of 51 years (range
15–87 years).
The final diagnosis were: in 751 cases multinodular
goiter (36.9%), in 615 differentiated carcinoma (30.2%),
in 424 Hashimoto’s thyroiditis (20.8%), in 215 Graves’
disease (10.6%), in 29 medullary carcinoma (1.4%).Histological diagnosis and surgical procedures are sum-
marized in Table 1.
In differentiated carcinoma, lymph node metastasis
were found in 49 patients (7.6%) and micrometastasis in
14 (2.21%). Totally lymph node metastasis were observed
in 61 patients (9.47%).
The study was approved by the Bioethics Commitee of
the University of Cagliari. All patients provided written
informed consent for the intervention and for the storage
and use of their data.
All operations were performed by three experienced
endocrine surgeons, with a standard Kocher’s incision. All
patients were submitted to preoperative and postoperative
laryngoscopy. Post-operative laryngoscopy was performed
2 days after the surgical procedure.
The recurrent laryngeal nerves were routinely identified
by visualization and completely exposed. In 1711/2034 op-
erations the relation between nerves and inferior thyroid
artery and its branches was described.
Recurrent laryngeal nerves were posterior to inferior
thyroid artery in 85.44% of cases on the right side and
82.81% on the left. Nerves were anterior in 5.4% of cases
on the right and 5.01% of cases on the left. Nerves with
extralaryngeal bifurcation were 2.38% on the right and
2.3% on the left, whilst course of the nerve between the
branches of the artery was found in 5.78% on the right
and 5.21% on the left. In 1% of cases a non recurrent
nerve or a nerve with an extralaryngeal trifurcation was
found.
Intraoperative neuromonitoring was performed in 1041
patients on the basis of the availability of the equipment
(2068 nerves at risk). All these patients undergone gen-
eral anesthesia and were intubated with Nerve Integrity
Monitor Standard Reinforced Electromiography Endo-
tracheal Tube (Medtronic Xomed). The tube was placed
with the middle of the blue-marked region (3 cm of the
exposed electrodes) well in contact with the true vocal
cords under direct laryngoscopy. When the monitor was
well set up, we routinely checked the impedance of elec-
trodes. A Prass monopolar stimulation probe (Medtronic
Xomed) was used for nerve stimulation during thyroidec-
tomy. EMG activity was recorded on a NIM-response 2.0
or 3.0 monitor (Medtronic Xomed). No muscle relaxants
were used after the skin flaps were elevated.
The neuromonitoring device was used in various phases
of the operation: at the beginning, a stimulation was done
to the level corresponding to the vagus nerve to ensure
that the monitoring system was working; after, to the
structure believed to be the inferior laryngeal nerve; at the
end, to the level of both the vagus and the recurrent nerve
after the removal of thyroid and the hemostasis of the
surgical field for predicting the postoperative outcome.
Patients in which the nerve monitoring did not function
properly were excluded from the study.
Table 1 Histological diagnosis and surgical procedures
Total n (%) Total thyroidectomy
n (%)
Completion thyroidectomy
n (%)
Total thyroidectomy + lymphectomy
n (%)
Group A 993 (100%) 854 (86%) 40 (4.03%) 99 (9.97%)
• Multinodular goiter 374 (37.66%) 337 (90.11%) 20 (5.35%) 17 (4.55%)
• Differentiated carcinoma 285 (28.7%) 212 (74.39%) 7 (2.46%) 66 (23.16%)
• Hashimoto’s thyroiditis 216 (21.75%) 195 (90.28%) 12 (5.56%) 9 (4.17%)
• Graves’ disease 104 (10.47%) 101 (97.12%) 1 (0.96%) 2 (1.92%)
• Medullary carcinoma 14 (1.41%) 9 (64.29%) 0 5 (35.71%)
Group B 1041 (100%) 895 (85.98%) 14 (1.34%) 132 (12.68%)
• Multinodular goiter 377 (36.22%) 341 (90.45%) 7 (1.86%) 29 (7.69%)
• Differentiated carcinoma 330 (31.7%) 238 (72.12%) 4 (1.21%) 88 (26.67%)
• Hashimoto’s thyroiditis 208 (19.98%) 199 (95.67%) 2 (0.96%) 7 (3.37%)
• Graves’ disease 111 (10.66%) 106 (95.5%) 1 (0.9%) 4 (3.6%)
• Medullary carcinoma 15 (1.44%) 11 (73.33%) 0 4 (26.67%)
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and patients who have undergone surgery with nerve
visualization alone.
Patients in which neuromonitoring was not utilized
(Group A) were 993 (1946 nerves at risk), 169 male and
824 female. 854 (86%) were submitted to total thyroidec-
tomy, 40 (4.03%) to completion total thyroidectomy and
99 (9.97%) to a total thyroidectomy associated to a VI
level lymphectomy. In this group diagnosis was benign
multinodular goiter in 374 (37.66%) patients, differenti-
ated carcinoma in 285 (28.7%), Hashimoto’s thyroiditis in
216 (21.75%), Graves’ disease in 104 (10.47%), medullary
carcinoma in 14 (1.41%).
Patients in which neuromonitoring was utilized (group B)
were 1041 (2068 nerves at risk), 250 male and 791 female.
895 (85.98%) were submitted to a total thyroidectomy,
14 (1.34%) to a completion total thyroidectomy and 132
(12.68%) to a total thyroidectomy associated to a VI
level lymphectomy. In this group diagnosis was benign
multinodular goiter in 377 (36.22%) patients, differenti-
ated carcinoma in 330 (31.7%), Hashimoto’s thyroiditis in
208 (19.98%), Graves’ disease in 111 (10.66%), medullary
carcinoma in 15 (1.44%).
Groups were homogeneous for characteristics of patients,
diagnosis and type of surgery.
We define "transient" an injury in which the motility of
the vocal cords recovered within 12 months after surgery.
Parameters were tested using the chi-square test. A logistic
regression analysis was fitted using transient and permanent
palsy as measurements of outcome. A p value of less than
0.05 was considered to be significant. Statistical analysis
was done with SPSS software (SPSS in, Chicago, III).
Results
In group A 26 unilateral recurrent laryngeal nerve paraly-
sis were observed (2.62%) of which 20 (2.01%) transientand 6 permanent (0.6%). Bilateral palsy was observed in 2
cases (0.2%); in one patient a vocal cord recovered com-
pletely three months after surgery. The patient, which has
had a completion thyroidectomy, had a nerve unilateral
palsy by previous surgery. In the other case, the patient
required a tracheostomy and the lesion was permanent.
Totally in group A 28 recurrent laryngeal nerve injuries
were observed (2.82%), 21 (2.11%) transient and 7 (0.7%)
permanent.
In group B 21 unilateral recurrent laryngeal nerve par-
alysis were observed (2.02%), 15 (1.44%) transient and 6
(0.57%) permanent. In this group of patients a bilateral
recurrent laryngeal palsy was observed in two cases
(0.19%) requiring a tracheostomy. Totally in group B 23
recurrent laryngeal nerve injuries were observed (2.21%),
in 17 cases (1.63%) transient and in 6 (0.58%) permanent.
Differences between the two groups were not statistically
significative (Table 2).
The mean postoperative hospital stay was 2 days in
both groups.
In group B we had 21 true positive cases, 1012 true
negative, 6 false positive and 2 false negative. Accuracy
of neuromonitoring was 99.2%, positive predictive value
77.8%, negative predictive value 99.8%. Sensitivity was
91.3% and specificity 99.4% (Table 3).
Recurrent laryngeal nerve paralysis in the two groups
in relation to type of surgery and histology are reported
in Table 2. Differences were not statistically significant.
No complications were attributable to the use of intra-
operative neuromonitoring.
Discussion
The incidence of recurrent laryngeal nerve palsy varies
from less than 1% to as high as 20% [26,32,38]. Several
factors influence the likelihood of nerve injury, including
the underlying disease, the extent of resection, and the
Table 2 Recurrent laryngeal nerve paralysis in the two groups in relation to type of surgery and histology
Group A (993 patients) n (%) Group B (1041 patients) n (%) p value
Recurrent nerve palsy 28 (2.82%) 23 (2.21%) 0.4604 p > 0.05
• Unilateral 26 (2.62%) 21 (2.02%) 0.4507 p > 0.05
• Bilateral 2 (0.2%) 2 (0.19%) 0.6503 p > 0.05
Transient nerve palsy 21 (2.11%) 17 (1.63%) 0.5232 p > 0.05
• Total thyroidectomy 15 (1.51%) 12 (1.15%) 0.6094 p > 0.05
• Completion thyroidectomy 2** (0.2%) 2 (0.19%) 0.583 p > 0.05
• Total thyroidectomy + lymphectomy 4 (0.4%) 3 (0.29%) 0.6981 p > 0.05
• Multinodular goiter 7 (0.7%) 8 (0.77%) 0.9875 p > 0.05
• Differentiated carcinoma 8** (0.81%) 4 (0.38%) 0.2569 p > 0.05
• Hashimoto’s thyroiditis 2 (0.2%) 4 (0.38%) 0.647 p > 0.05
• Graves’ disease 2 (0.2%) 1 (0.1%) 0.9546 p > 0.05
• Medullary carcinoma 0 0 - -
Permanent nerve palsy 7 (0.7%) 6 (0.58%) 0.9319 p > 0.05
• Total thyroidectomy 5* (0.5%) 5* (0.48%) 0.8081 p > 0.05
• Completion thyroidectomy 1 (0.1%) 0 0.5792 p > 0.05
• Total thyroidectomy + lymphectomy 1 (0.1%) 1 (0.1%) 0.6082 p > 0.05
• Multinodular goiter 2* (0.2%) 3 (0.29%) 0.9928 p > 0.05
• Differentiated carcinoma 3 (0.3%) 2* (0.19%) 0.8691 p > 0.05
• Hashimoto’s thyroiditis 1 (0.1%) 1 (0.1%) 0.4951 p > 0.05
• Graves’ disease 1 (0.1%) 0 0.974 p > 0.05
• Medullary carcinoma 0 0 - -
*One patient had bilateral nerve palsy.
**One patient with prior monolateral nerve palsy had controlateral nerve palsy in completion thyroidectomy.
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and reoperative thyroid procedures have a higher rate of
complications because of scarring and loss of normal
tissue planes [32,40-42]. Even experienced surgeons re-
port inadvertent injury to the nerve and persistent palsy
in about 1-2% of patients [32,38,39,43]. The reported
causes of recurrent laryngeal nerve injury result from
damage to the nerve’s anatomic integrity, thermal lesions,
excessive nerve skeletization, axon damage caused by
excessive strain, edema, hematoma, difficult trachealTable 3 Correlation of neuromonitoring results with
postoperative outcomes
True positives 21
True negatives 1012
False positives 6
False negatives 2
Accuracy 99.23%
Positive predictive value 77.77%
Negative predictive value 99.8%
Sensitivity 91.3%
Specificity 99.41%intubation, and neuritis [44]; but the actual causes of
recurrent laryngeal nerve injury, especially in those with
visual integrity, are still not well understood [27]. Several
studies have shown that surgeons were not aware of nerve
injury during the operation in most instances [27].
Visual identification of recurrent laryngeal nerve during
thyroid operations has been associated with lower rates
of permanent recurrent laryngeal nerve palsy and is
considered the gold standard of recurrent laryngeal
nerve treatment by many studies [27]. In 1938 Lahey
first dissected the recurrent laryngeal nerve in virtually
every case; careful dissection decreased the number of
injuries to the recurrent nerves and this approach is
accepted by most endocrine surgeons [26]. Nerve iden-
tification in certain types of operations may be very
difficult: these difficult cases include reoperations, surgery
for malignant disease, anatomic variants, and a history of
irradiation or inflammation [16,26,45]. Nerve monitoring
has been developed to facilitate the identification of
the recurrent laryngeal nerve during thyroid surgery
[18,23,26,45] and it may provide guidance for the surgeon
in such difficult situations [45].
There are a wide variety of techniques for nerve moni-
toring but the most common method in current use is a
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it that register effects of stimulation in the vocal cords
[25,46]. Despite the increasing popularity of this technol-
ogy, its impact in the avoidance of nerve injury and the
reduction of the incidence of postoperative nerve palsy
remain doubtful [23,25].
Several non-randomised studies demonstrated that an
improved intraoperative recurrent laryngeal nerve identifi-
cation rate with neuromonitoring resulted in lower palsy
rates than in historical patient cohorts with identification
alone [19]. The largest non-randomized multicenter trial
conducted in Germany with more than 16,000 patients
reported that the device could help in decreasing the
risk of nerve injury [13,19,46].
A large multicentre study of 4382 patients found a sta-
tistically significant reduction in rates of transient and
permanent recurrent laryngeal nerve paralysis with the
use of intraoperative nerve monitoring in surgery for
benign goiter; subgroup analysis of the same study found
higher rates of injury when intraoperative nerve moni-
toring was used for total thyroidectomy [19,25].
On the other side, a large single-centre study of 1000
consecutive nerve at risk found that continuous nerve
monitoring offered absolutely no benefit in reducing the
risk of nerve injury compared with the adoption of routine
nerve identification, with no difference in both the tem-
porary and the permanent nerve injury rates [23,25].
In the study of Dralle [6] intraoperative nerve monitoring
did not lower the risk of nerve injury although failure to
visually identify the nerve was associated with a higher
rate of injury; nerve injury rates were also higher for
low-volume hospitals and low-volume surgeons and this
fact was confirmed by others [5,23,26,33].
In the meta-analysis of Higgins [47], intraoperative
neuromonitoring and identification alone did not dem-
onstrate a statistically significant difference in rates of
total, transient, or persistent true vocal fold palsy with
adequately-powered sample sizes for all thyroid surgeries,
primary surgery, benign disease, and low-risk groups.
Other studies claim that the nerve monitoring is really
of value only in high-risk surgery, re-operative cases, or
recurrent goiters [25,33], but an impractically large num-
ber of patients would be needed because of the rarity of
nerve injury that is achieved in specialized centers [23].
In a prospective, randomized study of 1,000 patients
(1,000 nerves at risk for each group), the prevalence of
transient recurrent laryngeal nerve palsy was signifi-
cantly lower in the group of patients who had surgery
with intraoperative neuromonitoring by 2.9% in high-risk
patients and 0.9% in low-risk patients [5,48]. The rate of
permanent nerve palsy tended to be lower in operations
performed with intraoperative neuromonitoring (by 30%),
but the power of this study was not sufficient to validate
this difference [5].In our study the rates of postoperative recurrent laryn-
geal nerve paralysis did not differ significantly between the
two groups. The rate of transient and definitive recurrent
laryngeal nerve paralysis were 2.11% and 0.7% respectively
in group A (visualization alone) and 1.63% and 0.58% in
group B (with neuromonitoring); this slight difference
showed no statistical significance. No statistically signifi-
cant difference in the rate of vocal cord paralysis was
found in relation to the most common histological diag-
nosis. The main weakness with this and other studies on
this topic is just the inadequate power to identify a stat-
istical difference and this is a significant limitation. The
patients were not randomized which could lead to bias,
but the number of patients is very large (2034, 4014
nerves at risk) and the groups are very well matched. To
our knowledge, this is the largest mono-institutional
study published in the literature to date. Our opinion is
that neuromonitoring can help in the nerve identification
particularly in difficult situation such as reoperative
surgery or anatomic variations but it is very difficult to
demonstrate a statistically significant reduction in the
incidence of injuries because an extremely large num-
ber of patients would be needed. However it must be
said that difficult situations are not always predictable
preoperatively.
It has been observed that an anatomically intact nerve
does not always correlate with normal vocal fold function
and that the absence of signal does not necessarily imply
nerve dysfunction [33].
In the study of Thomusch [19] a normal intraoperative
neuromonitoring signal certainly excluded postoperative
vocal cord dysfunction. Indirect stimulation of the recur-
rent laryngeal nerve via the vagus nerve was a significantly
better predictor of postoperative dysfunction than direct
stimulation and should be always performed to monitor
the axonal excitability and mechanical intactness of the
nerve. Direct nerve stimulation is exclusively recommended
to detect the recurrent laryngeal nerve anatomy. After in-
direct nerve stimulation and a normal intraoperative neu-
romonitoring signal, the surgeon can extend the operation
to the contralateral side, being reassured that the nerve on
the resected side has a 99.6% chance of being intact [19].
In some cases an absent or abnormal intraoperative
neuromonitoring signal failed to predict reliably a post-
operative palsy. This failure may be due to problems
with the technical device, wrong application or continuous
relaxation during the operation with paralysed vocal mus-
culature, resulting in an absent signal. An absent or abnor-
mal signal was a rare phenomenon, with an incidence of
2.7% after indirect recurrent laryngeal nerve stimulation,
and in these cases, 29.8-45.9% of the patients had postop-
erative vocal cord dysfunction [19].
Our experience confirm the high accuracy (99.23%),
sensitivity (91.3%) and specificity (99.41%) of this method;
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value 99.8% confirming the data reported in the literature.
The use of these devices in thyroid surgery seems to
be more expensive than the conventional technique.
This is probably the major disadvantage [26] and par-
ticularly for this reason routine nerve monitoring is no
cost-effective [25].
The proponents of routine nerve monitoring claim that
its use can still be justified for bilateral surgery stating that
if nerve monitoring is undertaken after completion of one
side of the procedure and there is evidence of impaired
function, then the procedure should be abandoned to
avoid the risk of bilateral damage [5,18,19,25,45]. A failed
intraoperative neuromonitoring stimulation of the re-
current laryngeal nerve after resection of the first lobe
is specific enough to reconsider the surgical strategy in
patients with bilateral thyroid disease to surely prevent
bilateral recurrent laryngeal palsy [49].
Neuromonitoring provides comfort during thyroidec-
tomy for identification, dissection, and control of recurrent
laryngeal nerves; it can reduce the stress associated with
nerve dissection when a surgeon operates on a patient with
a challenging anatomy or in cases of extensive surgery [7]
but the main benefit remains its ability to guide the sur-
geon in cases of anatomical variations [45]. However the
use of neuromonitoring in only selected cases does not
allow adequate familiarity with the device and can lead to
pitfalls.
In our experience, the use of this technique has de-
creased the stress of the surgeon, facilitated the iden-
tification of the nerve and given greater safety in the
prosecution of the most difficult operations. These effects,
however, are very difficult to quantify. Recurrent laryngeal
nerve paresis occurrence diminishes the quality of life for
a few weeks to months after thyroid surgery; so any im-
provement in this field is welcome [5]. Recurrent laryngeal
nerve monitoring also allows for nerve function documen-
tation before and after thyroid resection (by printing the
electromyographic signal of evoked potentials), which is of
great importance in an increasing number of litigation [5].
Conclusions
Visual nerve identification remains the gold standard of
recurrent laryngeal nerve management in thyroid surgery.
The technique of intraoperative neuromonitoring is safe,
effective, and reliable in excluding postoperative recurrent
laryngeal nerve palsy. Neuromonitoring helps to identify
the recurrent laryngeal nerve, in particular in difficult
cases, but it did not decrease recurrent laryngeal nerve
injuries compared with visualization alone in this study.
Future studies are warranted to evaluate the benefit of
intraoperative neuromonitoring in thyroidectomy, espe-
cially in conditions in which the recurrent laryngeal
nerve is at high risk of injury.Competing interests
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